Doctor profile · Federal record
Dr. ISMAIL ALMOKYAD, MD
Nephrology Physician (CMS: NEPHROLOGY) · Student in an Organized Health Care Education/Training Program · TULSA, OK
- NPI 1649628991
- Accepts Medicare
- 16 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
1145 S UTICA AVE STE 364
TULSA, OK 741044004
(918) 712-5000 - Additional location
-
57 North St
Danbury, CT 068105660
(203) 743-0100
Credentials & registration
- NPI registered
- May 2016 — 10 yrs on file
- Profile last updated
- September 26, 2022
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207RN0300X — NUCC code
- State license (1)
- Oklahoma #37423
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1649628991. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,662
Distinct HCPCS
10
Medicare allowed
$234,914
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 349 | 164 | $75 | |
90961 |
Dialysis services, 2-3 physician visits per month (20 years or older) | 311 | 97 | $276 | |
90935 |
Hemodialysis procedure with physician evaluation | 186 | 86 | $68 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 165 | 106 | $88 | |
90960 |
Dialysis services, 4 or more physician visits per month (20 years or older) | 113 | 42 | $332 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 107 | 67 | $113 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 85 | 83 | $164 | |
99231 |
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 83 | 57 | $46 | |
90945 |
Dialysis procedure including 1 evaluation | 73 | 38 | $80 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 57 | 48 | $67 |
In context: peer comparison
Among 17 peers in this city , average services per provider: 149. This provider delivers 11× the peer median.Open Payments
Industry payments received
All-time total
$539
Transactions
33
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $211.14 | |
| AstraZeneca Pharmaceuticals LP | 6 | $143.85 | |
| Ardelyx, Inc. | 2 | $35.34 | |
| Amgen Inc. | 2 | $33.90 | |
| OPKO Pharmaceuticals, LLC | 2 | $31.99 | |
| Otsuka America Pharmaceutical, Inc. | 1 | $29.87 | |
| CALLIDITAS THERAPEUTICS US INC. | 1 | $18.14 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18.04 | |
| Travere Therapeutics, Inc. | 1 | $16.89 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
596
Patients
164
Total drug cost
$14,505
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Calcitriol | Generic | 149 | 36 | $2,643 |
| Furosemide | Generic | 78 | 32 | $524 |
| Potassium Chloride | Generic | 52 | 17 | $1,064 |
| Nifedipine Er (Nifedipine) | Brand | 47 | 19 | $2,002 |
| Amlodipine Besylate | Generic | 44 | 21 | $365 |
| Carvedilol | Generic | 40 | 14 | $493 |
| Hydralazine Hcl | Generic | 36 | 0 | $1,251 |
| Lisinopril | Generic | 28 | 13 | $216 |
| Sevelamer Carbonate | Generic | 27 | 0 | $3,989 |
| Losartan Potassium | Generic | 20 | 0 | $253 |